Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 8/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 5: Figure S5

Description: Differentially abundant taxa between the TB and TB + HRZ groups at 2months HR therapy.

Abundance in Group 1: decreased abundance in TB +HRZ group - 2months into HR therapy(W12)

NCBI	Quality Control	Links
Anaerovorax
Gordonibacter
Tyzzerella
Alkaliphilus
Robinsoniella
Roseburia
Acetivibrio
Arthrobacter
Mitsuokella
Acidaminobacter
Hespellia
Stomatobaculum
Dorea
Sporobacter
Clostridium
Butyricicoccus
Romboutsia
Peptococcus
Pediococcus
Turicibacter
Dysgonomonas
unclassified Coprobacter
Bacteroides

Revision editor(s): KateRasheed